PDIK1L and type 2 diabetes mellitus: HQ could ameliorate the insulin signaling pathway by upregulating casein kinase activity, regulating glucose and lipid metabolism, and enhancing IR, to treat T2DM [25]; HL could treat T2DM through an anti‐inflammatory effect [26].